Simple jQuery Dropdowns

Browsing by Author Jun Zou

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 3 of 3
Issue DateTitleAuthor(s)
1-Feb-2019Development of a patient-reported outcomes symptom measure for patients with nontransfusion-dependent thalassemia (NTDT-PRO <sup>©</sup> )Ali Taher; Vip Viprakasit; Maria Domenica Cappellini; Pranee Sutcharitchan; Richard Ward; Dalia Mahmoud; Abderrahmane Laadem; Anzalee Khan; Chad Gwaltney; Gale Harding; Kenneth Attie; Xiaosha Zhang; Jun Zou; Joseph Pariseau; X. Henry Hu; Antonis Kattamis; Evidera, USA; American University of Beirut Medical Center; Università degli Studi di Milano; Chulalongkorn University; Aghia Sophia Children's Hospital; Celgene Corporation; University of Toronto; Faculty of Medicine, Siriraj Hospital, Mahidol University; Nathan S. Kline Institute for Psychiatric Research; NeuroCog Trials; ERT; Acceleron Pharma
26-Mar-2020A phase 3 trial of luspatercept in patients with transfusion-dependent β-thalassemiaM. Domenica Cappellini; Vip Viprakasit; Ali T. Taher; Pencho Georgiev; Kevin H.M. Kuo; Thomas Coates; Ersi Voskaridou; Hong Keng Liew; Idit Pazgal-Kobrowski; G. L. Forni; Silverio Perrotta; Abderrahim Khelif; Ashutosh Lal; Antonis Kattamis; Efthymia Vlachaki; Raffaella Origa; Yesim Aydinok; Mohamed Bejaoui; P. Joy Ho; Lee Ping Chew; Ping Chong Bee; Soo Min Lim; Meng Yao Lu; Adisak Tantiworawit; Penka Ganeva; Liana Gercheva; Farrukh Shah; Ellis J. Neufeld; Alexis Thompson; Abderrahmane Laadem; Jeevan K. Shetty; Jun Zou; Jennie Zhang; Dimana Miteva; Tatiana Zinger; Peter G. Linde; Matthew L. Sherman; Olivier Hermine; John Porter; Antonio Piga; l'Institut des Maladies Génétiques Imagine; Azienda Ospedaliera Brotzu - Microcitemico; Centre National de Greffe de Moelle Osseuse; University Hospital St. Marina; American University of Beirut Medical Center; Hopital Farhat Hached Sousse; UCSF Benioff Children‘s Hospital; Università degli Studi di Milano; National and Kapodistrian University of Athens; St.George University Hospital; Hôpital Necker Enfants Malades; Università degli Studi della Campania Luigi Vanvitelli; Laikon General Hospital; UCL; Rabin Medical Center Israel; St. Jude Children's Research Hospital; Celgene Corporation; E.O. Ospedali Galliera; Royal Prince Alfred Hospital; University of Toronto; Keck School of Medicine of USC; University of Malaya Medical Centre; Hospital Sultanah Aminah; Università degli Studi di Torino; Faculty of Medicine, Siriraj Hospital, Mahidol University; Ege University Medical School; National Health Service; National Taiwan University; Hippokration General Hospital; Chiang Mai University; Celgene; Hospital Umum; Ann and Robert H. Lurie Children's Hospital of Chicago; Specialized Hospital for Active Treatment in Oncology; Hospital Sultanah Bahiyah; Acceleron Pharma
1-Feb-2019Validation of a patient-reported outcomes symptom measure for patients with nontransfusion-dependent thalassemia (NTDT-PRO <sup>©</sup> )Ali Taher; Maria Domenica Cappellini; Vip Viprakasit; Pranee Sutcharitchan; Dalia Mahmoud; Abderrahmane Laadem; Anzalee Khan; Chad Gwaltney; Gale Harding; Kenneth Attie; Xiaosha Zhang; Jun Zou; Joseph Pariseau; X. Henry Hu; Antonis Kattamis; Evidera, USA; American University of Beirut Medical Center; Università degli Studi di Milano; Chulalongkorn University; Aghia Sophia Children's Hospital; Celgene Corporation; Faculty of Medicine, Siriraj Hospital, Mahidol University; Nathan S. Kline Institute for Psychiatric Research; NeuroCog Trials; ERT; Acceleron Pharma